做多
PRTK - Bulls Almost Hit The Target...

Paratek Pharmaceuticals, Inc. engages in the development and commercialization of therapies based upon tetracycline chemistry. Its products include omadacycline and sarecycline, which are used for the treatment of community-acquired bacterial infections, including community-acquired bacterial pneumonia, acute bacterial skin and skin structure infections and urinary tract infections. The company was founded by Walter Gilbert and Stuart B. Levy in 1996 and is headquartered in Boston, MA.
SHORT INTEREST
10.98M 08/15/19
P/E Current
-1.09
P/E Ratio (with extraordinary items)
-1.02
Average Recommendation: BUY
Average Target Price: 21.33
SHORT INTEREST
10.98M 08/15/19
P/E Current
-1.09
P/E Ratio (with extraordinary items)
-1.02
Average Recommendation: BUY
Average Target Price: 21.33
免责声明
这些信息和出版物并非旨在提供,也不构成TradingView提供或认可的任何形式的财务、投资、交易或其他类型的建议或推荐。请阅读使用条款了解更多信息。
免责声明
这些信息和出版物并非旨在提供,也不构成TradingView提供或认可的任何形式的财务、投资、交易或其他类型的建议或推荐。请阅读使用条款了解更多信息。